Long‐term seizure reduction with vagus nerve stimulation in Dravet syndrome
Developmental Medicine & Child Neurology · 2026
DOI: 10.1111/dmcn.70127 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Developmental Medicine & Child Neurology, 2026. Verfasst von Sunanjay Bajaj und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Epilepsies, Myoclonic, Seizures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Aim
To assess the long‐term efficacy of vagus nerve stimulation (VNS) in Dravet syndrome and identify key factors influencing treatment response.
Method
We conducted a two‐center, retrospective cohort study of 15 patients (six females, nine males; median age at seizure onset 4 months [range 2–12 months]) with Dravet syndrome who underwent VNS implantation. Seizure frequency was evaluated over 12 months and up to 10 years after implantation. Linear mixed‐effects regression was used to analyze the impact of antiseizure medications (ASMs) and VNS parameters on seizure outcomes.
Results
A 50% or greater reduction in seizure frequency was observed in 93.3% (14 of 15) of patients at 12 months and 86.7% (13 of 15) of patients across the 10‐year follow‐up. This seizure reduction was independent of ASM use; the VNS duty cycle was a significant predictor of seizure reduction. Two individuals (13.3%) experienced minor adverse events.
Interpretation
VNS provides durable seizure reduction in Dravet syndrome, independent of ASM adjustments. These findings highlight the importance of early VNS initiation and parameter optimization in managing genetically defined epilepsy syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
- Department of Neurology, Mayo Clinic Florida, Jacksonville, FL, USA.
- Department of Pediatric Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
- Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
- Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
- Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
ORCID-Profile: Sunanjay Bajaj
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Bajaj, S., Ivaniuk, A., Bruenger, T., Shah, M. N., Alexopoulos, A., Lhatoo, S. D., Knight, E. P., Von Allmen, G., Lal, D., & SCN1A VNS Study Group (2026). Long‐term seizure reduction with vagus nerve stimulation in Dravet syndrome. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70127
Vancouver
Bajaj S, Ivaniuk A, Bruenger T, Shah MN, Alexopoulos A, Lhatoo SD, et al. Long‐term seizure reduction with vagus nerve stimulation in Dravet syndrome. Developmental Medicine & Child Neurology. 2026. doi:10.1111/dmcn.70127
BibTeX
@article{Bajaj2026,
author = {Bajaj, Sunanjay and Ivaniuk, Alina and Bruenger, Tobias and Shah, Manish N and Alexopoulos, Andreas and Lhatoo, Samden D and Knight, Elia Pestana and Von Allmen, Gretchen and Lal, Dennis and SCN1A VNS Study Group, SCN1A VNS Study Group},
title = {Long‐term seizure reduction with vagus nerve stimulation in Dravet syndrome},
journal = {Developmental Medicine & Child Neurology},
year = {2026},
doi = {10.1111/dmcn.70127}
}
EUVIMED